Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 4 - What They Never Told You

Walgreens to pay up to $350 million in U.S. opioid settlement

Walgreens has agreed to pay up to $350 million in a settlement with the U.S. Department of Justice, who accused the pharmacy of illegally filling millions of prescriptions in the last decade for opioids and other controlled substances

The Independent UK

‘It might be gutted’ – Boots braces for dose of private equity’s bitter medicine

The 176-year-old chemist is preparing for another change of hands. What’s the mood of staff and residents at its home base in Nottinghamshire?

The Guardian - UK

With Palantir stock taking off, CEO Alex Karp has finally been vindicated

Palantir’s strategy of building software for defense and intelligence agencies has taken off, and Silicon Valley is following Karp’s lead.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Walgreens Comeback? Private Equity Circling for a Buyout

Walgreens stock might be a good name to consider in the coming months, especially as new developments might boost a takeover bid.

MarketBeat

Suspect who killed Walgreens worker ‘had grudge against big pharmacies’, police say

Narciso Gallardo Fernandez, 30, was arrested and charged with murder after he was captured on surveillance footage from inside the store waving a gun around

The Independent UK

26 Modern Conveniences That Are, Ironically, Not Very Convenient At All

Just because something is new doesn’t automatically make it better, easier to use, and more consumer-friendly than older technology. The post 26 Modern Conveniences That Are, Ironically, Not Very Convenient At All first appeared on Bored Panda.

Bored Panda

38 People Are Sharing Modern ‘Conveniences’ That They Can’t Stand

Just because something is new doesn’t automatically make it better, easier to use, and more consumer-friendly than older technology. The post 38 People Are Sharing Modern ‘Conveniences’ That They Can’t Stand first appeared on Bored Panda.

Bored Panda

Read news from The Economist, FT, and more,
with one subscription

Walgreens employee arrested for assault after attempting to stop shoplifter

A Walgreens employee is behind bars on assault with a deadly weapon charges in San Francisco after he was accused of stabbing a would-be shoplifter in the eye.

The Independent UK

Some La Roche-Posay, Proactiv and Walgreens acne treatments recalled due to benzene levels

The Food and Drug Administration is asking retailers to remove a small number of acne creams from their shelves that contain slightly elevated levels of a chemical linked to cancer

The Independent UK

Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet

Walgreens Boots Alliance agreed to an $11.45 per share buyout by Sycamore Partners, but shareholders can reject the deal and holdout for a better offer.

MarketBeat

Texas cities run short of MMR vaccine as measles outbreak drives demand

Pharmacies are struggling with supplies as fatal outbreak expands and health secretary sows disinformation

The Guardian - US

Stock Market Today: Stocks Swing Higher on Powell Speech

Investors cheered after Fed Chair Powell repeated his confidence in the strength of the U.S. economy.

Kiplinger

Walgreens Is Going Private. Is It Too Late to Buy WBA Stock?

Walgreens stock opened about 8% up on Friday following news it has agreed to go private in a $23.7 billion deal with Sycamore Partners.

Barchart

US owner of UK pharmacy chain Boots to be taken private in $10bn deal

Sale of Walgreens Boots Alliance to Sycamore Partners will mean further uncertainty for staff of pharmacy chain

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

Walgreens agrees to be acquired by private equity firm for almost $10 billion

Walgreens Boots Alliance says it has agreed to be acquired by the private equity firm Sycamore Partners as the struggling retailer looks to turn itself around after years of losing money

Barchart

Analysts Are Pounding the Table: Sell This High-Yield Dividend Stock Now

Walgreens Boots Alliance, once a reliable dividend stock, is now under scrutiny as it suspends dividend payments, faces declining retail performance, and navigates potential takeover talks.

Kiplinger

Stock Market Today: Stocks Recover From Trump-Zelensky Slide

Reports of a combative meeting between the two leaders sent stocks temporarily lower Friday afternoon.

Barchart

Take a LEAP of Faith With These 3 Unusually Active Call Options

Walgreens Boots Alliance had five unusually active call options on Thursday. Three of the struggling drug store chain's calls expire in nearly three years. If you're an aggressive investor, you might take a LEAP of faith.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation

Why community pharmacies are closing – and what to do if your neighborhood location shutters

Neighborhood pharmacies are rapidly shuttering.

MarketBeat

High-Yield Healthcare: 3 Stocks With Strong Dividends

This article covers three healthcare stocks that offer dividend yields of at least 7% and dives deeper into the fundamentals to determine if they're good buys.

International Business Times

Flu Index Shows Cases Increasing For 4 Weeks In A Row. Here Are The 5 States Hit The Worst

Flu cases are "significantly higher" than the same period last year according to the Walgreens Flu Index.

International Business Times

Walgreens Manager Pleads Guilty In String Of Inside-Job Armed Robberies

London Teeter faces up to 20 years in prison when she is sentenced in federal court.

The Independent UK

Grieving parents couldn’t understand how their son died of an asthma attack. Then they found out how much his meds now cost

EXCLUSIVE: Shanon and Bill Schmidtknecht tell Rhian Lubin of their grief for son Cole and their fight for a fairer health insurance system

The Independent UK

Couple sues Walgreens and Optum Rx over son’s death after $500 price rise for asthma meds

A Wisconsin couple is suing Walgreens and a pharmacy benefits company alleging their son died because he couldn't afford a sudden $500 jump in the cost of his asthma medication

Kiplinger

Stock Market Today: Trump Tariff Worries Pressure Stocks

Stocks swung lower Friday after the White House confirmed it will impose tariffs on Mexico, Canada and China beginning tomorrow.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.